Number (%) | Crude HR | Adjusted HRa (95% CI) | |
---|---|---|---|
Age at diagnosis | |||
> 65 years | 1018 (63) | 1.25 | 1.52 (1.14–2.03) |
61–65 years | 274 (17) | 0.99 | 1.01 (0.70–1.47) |
≤ 60 years | 328 (20) | Reference | Reference |
Male sex | 1157 (71) | 1.76 | 1.51 (1.15–1.96) |
FVC (% predicted) | |||
< 50% | 78 (5) | 5.62 | 3.45 (2.28–5.23) |
50–75% | 669 (41) | 2.66 | 1.89 (1.47–2.42) |
> 75% | 873 (54) | Reference | Reference |
TLCO (% predicted) | |||
≤ 35% | 419 (26) | 6.22 | 3.52 (2.40–5.18) |
36–55% | 687 (42) | 3.90 | 3.05 (2.13–4.36) |
> 55% | 514 (32) | Reference | Reference |
Pulmonary hypertension | 123 (8) | 2.63 | 2.04 (1.46–2.86) |
Lung cancer | 19 (1) | 3.47 | 2.55 (1.33–4.92) |
Long-term oxygen therapy | 327 (20) | 2.35 | 1.49 (1.19–1.88) |